Head of the Kolling’s Renal Research Laboratory Professor Carol Pollock said this exciting new technology provides clear information about kidney pathology by examining kidney cells in urine.
“Importantly, this enables early intervention and effective management," she said.
Project co-lead Associate Professor Sonia Saad said that being able to assess kidney pathology in a non-invasive way brings a host of benefits.
“It will enable clinicians to examine the effects of new drugs on the kidney and monitor kidney pathology over time,” she said.
“This will provide valuable information on the effectiveness of treatments.”
PhD student Dr Henry Wu has welcomed the chance to be involved in the project.
“It’s been rewarding to have been part of the development of this important new technology. We would like to see it applied broadly across clinical practice given the health and economic benefits of this approach,” he said.
The study is being led by Professor Pollock and Associate Professor Saad from the University of Sydney in collaboration with Professor Ewa Goldys and her team from the University of New South Wales.